G. Schoenhard

发表

Aflatoxicol-induced hepatocellular carcinoma in rainbow trout (Salmo gairdneri) and the synergistic effects of cyclopropenoid fatty acids.

J. Hendricks, R. Sinnhuber, J. Wales, 1981, Cancer research.

Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.

D. Yang, M. Rock, R. Bible, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Suitability of the dog as an animal model for evaluating theophylline absorption and food effects from different formulations

K. Kowalski, A. Karim, G. Schoenhard, 1990 .

Aflatoxin B1 metabolism to aflatoxicol and derivatives lethal to Bacillus subtilis GSY 1057 by rainbow trout (Salmo gairdneri) liver.

R. Sinnhuber, L. M. Libbey, D. J. Lee, 1976, Cancer research.

Enhancement of Nasal Delivery of a Renin Inhibitor in the Rat Using Emulsion Formulations

R. Schmidt, T. Needham, T. Kararli, 1992, Pharmaceutical Research.

Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.

G. Schoenhard, C. Cook, J. Oppermann, 1993, The Journal of pharmacology and experimental therapeutics.

Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid

G. Schoenhard, B. Tsai, J. Stolzenbach, 1991, Digestive Diseases and Sciences.

Species Dependent Esterase Activities for Hydrolysis of an Anti-HIV Prodrug Glycovir and Bioavailability of Active SC-48334

A. Karim, G. Schoenhard, C. Cook, 1995, Pharmaceutical Research.

Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: Mutagenic metabolites unique to potassium canrenoate

P. Finnegan, A. Patel, R. Bible, 2004, Archives of Toxicology.

Transdermal drug delivery systems of albuterol: in vitro and in vivo studies.

T. Needham, R. Gokhale, G. Schoenhard, 1992, Journal of pharmaceutical sciences.

Improvement of bioavailability of the HIV protease inhibitor SC-52151 in the beagle dog by coadministration of the CYP3A4 inhibitor, ketoconazole.

G. Schoenhard, J. Yuan, J. Stolzenbach, 1997, Xenobiotica; the fate of foreign compounds in biological systems.

Metabolism and pharmacokinetic studies of misoprostol

G. Schoenhard, F. E. Kohn, J. Oppermann, 1985, Digestive Diseases and Sciences.

Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.

J Y Zhang, E. Burton, J. Cogburn, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Mechanism of Compound- and Species-Specific Food Effects of Structurally Related Antiarrhythmic Drugs, Disopyramide and Bidisomide

A. Karim, G. Schoenhard, C. Cook, 1998, Pharmaceutical Research.

Metabolism of a novel antiarrhythmic agent, bidisomide, in man: use of high resolution mass spectrometry to distinguish desisopropyl bidisomide from desacetyl bidisomide.

A. Karim, J. Hribar, G. Schoenhard, 1995, Xenobiotica; the fate of foreign compounds in biological systems.

Aflatoxin B 1 Metabolism to Aflatoxicol and Derivatives Lethal to Bacillus subtilis GSY 1057 by Rainbow Trout ( Salmo gairdneri ) Liver 1

R. Sinnhuber, L. M. Libbey, G. Schoenhard, 2006 .

N-Oxygenation of Oxycodone and Retro-reduction of Oxycodone N-Oxide

J. Cashman, A. D. de Kater, G. Schoenhard, 2019, Drug Metabolism and Disposition.

Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.

Laura B. Ferguson, V. Hesselbrock, A. Goate, 2015, Alcoholism, clinical and experimental research.

Demonstration of specific E-type prostaglandin receptors using enriched preparations of canine parietal cells and [3H]misoprostol free acid.

P. Collins, G. Schoenhard, B. Tsai, 1987, The American journal of medicine.

A nonequilibrium radioimmunoassay for angiotensin II.

S. Paulson, G. Schoenhard, K. Miller, 1994, Journal of pharmacological and toxicological methods.

The pharmacokinetics and metabolism of SC-53228, a specific leukotriene B4 receptor antagonist

S. Paulson, G. Schoenhard, D. Fretland, 1995, Inflammation Research.

A method for rapid and frequent blood collection from the rat tail vein.

G. Schoenhard, P. Frank, E. Burton, 1991, Journal of pharmacological methods.

Mechanisms of Food Effects of Structurally Related Antiarrhythmic Drugs, Disopyramide and Bidisomide in the Rat

G. Schoenhard, C. Cook, Guangyu Xu, 1997, Pharmaceutical Research.

E-type prostaglandin binding sites in isolated canine parietal cells: elucidation with (3H) misoprostol free acid.

P. Collins, G. Schoenhard, B. Tsai, 1987, Zeitschrift fur Gastroenterologie.

Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib.

E. Burton, B. Reitz, B. Reitz, 1999, Drug metabolism and disposition: the biological fate of chemicals.

The pharmacokinetics of oxycodone and its metabolites following single oral doses of Remoxy®, an abuse-deterrent formulation of extended-release oxycodone, in patients with hepatic or renal impairment.

A. D. de Kater, N. Friedmann, B. Malhotra, 2015, Journal of Opioid Management.

Oral Delivery of a Renin Inhibitor Compound Using Emulsion Formulations

T. Needham, T. Kararli, G. Schoenhard, 1992, Pharmaceutical Research.

Pharmacokinetics of a Novel Antiarrhythmic Drug, Actisomide

A. Karim, G. Schoenhard, C. Cook, 1993, Pharmaceutical Research.